Working Prototype
Complete on-device audio-visual pipeline integration, dynamic gating, and real-time interface build.
Strategic Roadmap
12-Month Milestones & 5-Year Commercial Direction.
A structured progression from invention and prototype development to rigorous prospective validation, public beta, and long-term medical device / software licensing pathways.
Near-Term Focus
The 12-Month Progression
Three primary milestones driving technical and product readiness.
Rigorous Validation
Prospective dataset completion, clinical rater alignment, multimodal ablations, and subgroup fairness audits.
Public Beta Release
Consent-first public beta deployment for user self-understanding, fatigue tracking, and feedback collection.
Commercial Trajectory
Long-Term Licensing & Business Models
NDMS is being developed as a scalable technology and licensing enterprise. Commercial offerings will launch progressively following validation.
Consumer Self-Support App
Privacy-first mobile and web application providing personal masking feedback, rest planning, and fatigue regulation.
Consumer SoftwareTherapist & Clinic Dashboard
Per-seat licensing for clinical psychologists and neurodiversity coaches conducting session reviews with client consent.
Clinic SaaSDeveloper API & SDK
Licensing edge audio-visual feature extraction and dynamic masking risk models to digital health and accessibility platforms.
API LicensingResearch & Academic Licenses
Full research platform access with raw feature streams and optional EEG distillation modules for university studies.
Academic LicensingStrategic Technology Partnerships
Co-development and enterprise licensing with digital health, workplace wellbeing, and neurotechnology platforms.
Enterprise LicensingSoftware as a Medical Device (SaMD)
Around Year 3, following extensive clinical evidence generation, initiating formal FDA/CE medical device approval pathways for potential regulated clinical decision-support indication, subject to validation and regulatory classification.
Year 3+ Medical Strategy